Apunte histórico sobre la quinidina

Margarita Dorantes Sánchez

Autores/as

Margarita Dorantes Sánchez

Resumen

Apunte histórico sobre la quinidina

Descargas

Los datos de descargas todavía no están disponibles.

Citas

1. Belhassen B. Is quinidine the ideal drug for Brugada syndrome? Heart Rhythm. 2012;9(12):2001-2.

2. Yang F, Hanon S, Lam P, Schweitzer P. Quinidine revisited. Am J Med. 2009;122(4):317-21.

3. Viskin S. Idiopathic ventricular fibrillation "Le syndrome d'Haissaguerre" and the fear of J waves. J Am Coll Cardiol. 2009;53(7):620-2.

4. Selzer A, Wray HW. Quinidine syncope, paroxysmal ventricular fibrillation ocurring during treatment of chronic atrial arrhythmias. Circulation. 1964;30(1):17-26.

5. Márquez MF, Bonny A, Hernández-Castillo E, De Sisti A, Gómez-Flores J, Nava S, et al. Long-term efficacy of low doses of quinidine on malignant arrhythmias in Brugada syndrome with an implantable cardioverter-defibrillator: a case series and literature review. Heart Rhythm. 2012;9(12):1995-2000.

6. RuDusky BM. Quinidine as an antiarrhythmic. Chest. 2001;119(5):1617-8.

7. Viskin S, Wilde AAM, Guevara-Valdivia ME, Daoulah A, Krahn AD, Zipes DP, et al. Quinidine, a life-saving medication for Brugada syndrome, is inaccesible in many countries. J Am Coll Cardiol. 2013;61(23):2383-7.

8. Antzelevitch C, Fish JM. Therapy for the Brugada syndrome. En: Kass RS, Clancy CE eds. Basis and treatment of cardiac arrhythmias. New York: Springer-Verlag Berlín Heidelberg, 2006; p. 305-30.

9. Olsson G. Market withdrawal of quinidine bisulfate (kinidin durules) in 2006. Heart Rhythm. 2010;7(6):864.

10. Belhassen B, Glick A, Viskin S. Excellent long-term reproducibility of the electrophysiologic efficacy of quinidine in patients with idiopathic ventricular fibrillation and Brugada syndrome. Pacing Clin Electrophysiol. 2009;32(3):294-301.

11. Viskin S, Antzelevitch C, Márquez MF, Belhassen B. Quinidine: a valuable medication joins the list of "endangered species". Europace. 2007;9(12):1105-6.

12. Viskin S, Wilde AAM, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: time for a prospective registry. Heart Rhythm. 2009;6(3):401-4.

13. Viskin S, Belhassen B, Wilde AAM. Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine. Heart Rhythm. 2010;7(6):863.

14. Estes NAM, Page RL. Response – Irreplaceable antiarrhythmic medications are disappearing: the case of quinidine. Heart Rhythm. 2010;7(6):863-4.

15. Vardas PE, Kanoupakis EM. Old drugs never die; they just fade away. Heart Rhythm. 2010;7(6):864.

16. Adler A, Nordkamp LO, Crotti L, Schwartz P, Castelletti S, Veltmann C, et al. Empiric quinidine for asymptomatic Brugada syndrome – Preliminary results of an international registry. Heart Rhythm. 2012;9(11):1918-9.

17. Laurent G, Saal S, Amarouch MY, Béziau DM, Marsman RFJ, Faivre L, et al. Multifocal ectopic Purkinje-related premature contractions. A new SCN5A-related cardiac channelopathy. J Am Coll Cardiol. 2012;60(2):144-56.

18. Yan GX, Antzelevitch C. Cellular basis for the Brugada syndrome and other mechanisms of arrhythmogenesis associated with ST segment elevation. Circulation. 1999;100(15):1660-6.

19. Alings M, Dekker L, Sadee A, Wilde A. Quinidine induced electrocardiographic normalization in two patients with Brugada syndrome. Pacing Clin Electrophysiol. 2001;24 (9 Pt 1):1420-2.

20. Belhassen B, Viskin S, Fish R, Glick A, Setbon I, Eldar M. Effects of electrophysiologic-guided therapy with Class IA antiarrhythmic drugs on the long-term outcome of patients with idiopathic ventricular fibrillation with or without the Brugada syndrome. J Cardiovasc Electrophysiol. 1999;10(10):1301-12.

21. Belhassen B, Viskin S, Antzelevitch C. The Brugada syndrome: is an implantable cardioverter defibrillator the only therapeutic option? Pacing Clin Electrophysiol. 2002;25(11):1634-40.

22. Hermida JS, Denjoy I, Clerc J, Extramiana F, Jarry G, Milliez P, et al. Hydroquinidine therapy in Brugada syndrome. J Am Coll Cardiol. 2004;43(10):1853-60.

23. Mok NS, Chan NY, Chiu AC. Successful use of quinidine in treatment of electrical storm in Brugada syndrome. Pacing Clin Electrophysiol. 2004;27(6 Pt 1):821-3.

24. Belhassen B, Viskin S. Pharmacologic approach to therapy of Brugada syndrome: quinidine as an alternative to ICD therapy?. En: Antzelevitch C, Brugada P, Brugada J, Brugada R, eds. The Brugada syndrome: from bench to bedside. Oxford: Blackwell Futura, 2004; p. 202-11.